International Association for the Study of Lung Cancer (IASLC)-18th World Conference on Lung Cancer (WCLC 2017) Yokohama, Japan - October 15-18, 2017

被引：1

作者：

Watt, J. ^{[1
]}

机构：

[1] Clarivate Analyt, London, England

来源：

DRUGS OF THE FUTURE | 2017年 / 42卷 / 11期

关键词：

LOXO-292; BIW-8962; Lorlatinib; JNJ-64041757; Poziotinib;

D O I：

10.1358/dof.2017.042.11.2739614

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The International Association for the Study of Lung Cancer (IASLC)'s 18th World Conference on Lung Cancer in Yokohama, Japan, was the group's second annual meeting, having been biennial until 2015, demonstrating the fast pace of development in the area of lung cancer. Attendees with medical, scientific, government and industry backgrounds gathered to present and discuss thoracic malignancies throughout the world to advance their therapy. This report highlights presentations from the 3-day meeting.

引用

页码：723 / 725

页数：3